<?xml version="1.0" encoding="UTF-8"?>
<ref id="R23">
 <label>23</label>
 <mixed-citation publication-type="journal">
  <person-group person-group-type="author">
   <string-name>
    <surname>Morand</surname>
    <given-names>EF</given-names>
   </string-name>, 
   <string-name>
    <surname>Furie</surname>
    <given-names>R</given-names>
   </string-name>, 
   <string-name>
    <surname>Tanaka</surname>
    <given-names>Y</given-names>
   </string-name>, 
   <etal>et al</etal>
  </person-group>. 
  <article-title>Trial of anifrolumab in active systemic lupus erythematosus</article-title>. 
  <source>N Engl J Med</source>
  <year>2020</year>;
  <volume>382</volume>:
  <fpage>211</fpage>â€“
  <lpage>21</lpage>. 
  <pub-id pub-id-type="doi">10.1056/NEJMoa1912196</pub-id>
  <?supplied-pmid http://www.ncbi.nlm.nih.gov/pubmed/31851795?>
  <pub-id pub-id-type="pmid">31851795</pub-id>
 </mixed-citation>
</ref>
